Newborn screening for critical congenital heart disease: Essential public health roles for birth defects monitoring programs

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 94, Issue 12, 2012, Pages 965-969

  Olney, Richard S ^a   Botto, Lorenzo D ^b,c  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UTAH DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTITUDE; BIRTH DEFECT; CONGENITAL HEART DISEASE; EDITORIAL; FETUS; FOLLOW UP; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; NEWBORN; NEWBORN SCREENING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUBLIC HEALTH;

CRITICAL ILLNESS; DATA COLLECTION; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; POPULATION SURVEILLANCE; PROGRAM EVALUATION; PUBLIC HEALTH; UNITED STATES;

EID: 84871167873     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23103     Document Type: Editorial

References (22)

1. Aamir T, Kruse L, Ezeakudo O. 2007. Delayed diagnosis of critical congenital cardiovascular malformations (CCVM) and pulse oximetry screening of newborns. Acta Paediatr 96: 1146-1149.
2. Bedard T, Lowry RB, Sibbald B, et al. 2012. Congenital heart defect case ascertainment by the Alberta Congenital Anomalies Surveillance System. Birth Defects Res A Clin Mol Teratol 94: 449-458.
3. Centers for Disease Control and Prevention. 2012. Newborn screening for critical congenital heart disease: potential roles of birth defects surveillance programs - United States, 2010-2011. MMWR Morb Mortal Wkly Rep 61: 849-853.
4. Chang RK, Gurvitz M, Rodriguez S. 2008. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med 162: 969-974.
5. Correa A, Kirby RS. 2010. An expanded public health role for birth defects surveillance. Birth Defects Res A Clin Mol Teratol 88: 1004-1007.
6. de-Wahl Granelli A, Wennergren M, Sandberg K, et al. 2009. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39, 821 newborns. BMJ 338: a3037.
7. Ewer AK, Furmston AT, Middleton LJ, et al. 2012. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess 16: v-xiii, 1-184.
8. German RR, Lee LM, Horan JM, et al. 2001. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 50: 1-35.
9. Hall HI, Correa A, Yoon PW, et al. 2012. Lexicon, definitions, and conceptual framework for public health surveillance. MMWR Surveill Summ 61 Suppl: 10-14.
10. Kemper AR, Boyle CA, Aceves J, et al. 2008. Long-term follow-up after diagnosis resulting from newborn screening: statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Genet Med 10: 259-261.
11. Kemper AR, Mahle WT, Martin GR, et al. 2011. Strategies for implementing screening for critical congenital heart disease. Pediatrics 128: e1259-e1267.
12. Khoury MJ. 1996. From genes to public health: the applications of genetic technology in disease prevention. Genetics Working Group. Am J Public Health 86: 1717-1722.
13. Koppel RI, Druschel CM, Carter T, et al. 2003. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics 111: 451-455.
14. Kuehl KS, Loffredo CA, Ferencz C. 1999. Failure to diagnose congenital heart disease in infancy. Pediatrics 103(4 Pt 1): 743-747.
15. Mahle WT, Martin GR, Beekman RH3rd, et al. 2012. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 129: 190-192.
16. Mahle WT, Newburger JW, Matherne GP, et al. 2009. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation 120: 447-458.
17. Mai CT, Law DJ, Mason CA, et al. 2007. Collection, use, and protection of population-based birth defects surveillance data in the United States. Birth Defects Res A Clin Mol Teratol 79: 811-814.
18. Mai CT, Riehle-Colarusso T, O'Halloran A, et al. 2012. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005-2009: Featuring critical congenital heart defects targeted for pulse oximetry. Birth Defects Res A Clin Mol Teratol (this issue).
19. Ng B, Hokanson J. 2010. Missed congenital heart disease in neonates. Congenit Heart Dis 5: 292-296.
20. Pass KA, Lane PA, Fernhoff PM, et al. 2000. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr 137(4 Suppl): S1-S46.
21. Riede FT, Wörner C, Dähnert I, et al. 2010. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine - results from a prospective multicenter study. Eur J Pediatr 169: 975-981.
22. Thangaratinam S, Brown K, Zamora J, et al. 2012. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 379: 2459-2464.